Quick Answer
Renalytix plc reported Stockholders Equity of -$7.85 million for the year ending 2024.
- Renalytix plc showed a decrease of -212.7% in Stockholders Equity from 2023 to 2024.
- This data is from Renalytix plc's annual report (Form 10-K), filed with the SEC on September 30, 2024.
- XBRL data for this metric is available from 2018 to 2024 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2022: $18.84 million | Q4 2022: $8.89 million | Q1 2023: $18.10 million | Q2 2023: $6.97 million | Q3 2023: -$1.49 million | Q4 2023: -$7.96 million | Q1 2024: -$11.11 million | Q2 2024: -$7.85 million | Q3 2024: -$11.32 million.
- Over the full 7 years of available data (2018 to 2024), Renalytix plc's Stockholders Equity has declined by 1,464.5%.
- Historical annual values: Fiscal year 2024: -$7.85 million | Fiscal year 2023: $6.97 million | Fiscal year 2022: $30.61 million | Fiscal year 2021: $71.46 million | Fiscal year 2020: $15.91 million | Fiscal year 2019: $8.55 million | Fiscal year 2018: -$502.0 thousand.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: